Specialist market access professional who is highly skilled in cost-effectiveness analyses, PBS pricing negotiations, financial analyses and revenue calculators
Adrian joined HTAnalysts in May 2018 as a Consultant, rapidly gained expertise and established himself as a valuable and integral part of the team. He now performs the critical role of Engagement Manager. Adrian specialises in the development of economic analyses and financial value tools for pharmaceuticals and medical technology. During his time with HTAnalysts, Adrian has completed several PBAC, MSAC and PHARMAC submissions, including the development of multiple test and treatment cost-utility models for co-dependant technologies. Adrian has also created many bespoke financial impact calculator tools to demonstrate the value of health technologies to different stakeholders and represent savings not captured under traditional funding mechanisms. Beyond health technology assessment in Australia, Adrian has created budget impact and cost-effectiveness analyses for multiple countries including China, Korea, Vietnam, UK, USA, Germany, France, Italy, and Belgium.
In addition to health economics and market access, Adrian has been involved in the development of clinical practice guidelines, systematic review and meta-analyses, evaluation of reimbursement submissions, and health technology due diligence assessment.
Prior to joining HTAnalysts, Adrian completed his Master of Health Technology Innovation at The University of Sydney, where he was awarded a place on the University of Sydney’s School of IT Postgraduate Honour Roll for his work in agent-based modelling. He is skilled in TreeAge, BaseCase, Excel and advanced VBA.